Phase II study of the efficacy and safety of cisplatin-epinephrine injectable gel administered to patients with unresectable hepatocellular carcinoma.
Leung TW, Yu S, Johnson PJ, Geschwind J, Vogl TJ, Engelmann K, Gores GJ, Giovannini M, O'Grady J, Heneghan M, Stewart M, Orenberg EK, Thuluvath PJ.
J Clin Oncol. 2003 Feb 15;21(4):652-8.PMID: 12586802 [PubMed - indexed for MEDLINE]Related articles